Recent Posts
- SpliceBio Appoints Leading Ophthalmology Expert Aniz Girach as Chief Medical Officer
- SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease
- SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program
- Splice Bio awarded with a “Colaboración Público-Privada” grant
- SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline
Popular Posts
- SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease October 17, 2023
- SpliceBio Appoints Leading Ophthalmology Expert Aniz Girach as Chief Medical Officer January 3, 2024
- SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program June 20, 2023
Recent Comments